Cardiovascular Effects of FR34235, a New Dihydropyridine Slow Channel Blocker, in Isolated Rabbit Myocardium and Aorta

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  1983-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-198309000-00020PMID 6195473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of vascular smooth muscle of rat aorta by noradrenaline and depolarization: Two different mechanisms

  2004cited by this paper
• Beneficial effects of the dihydropyridine calcium antagonist, FR 34235, in a chronic coronary occlusion model.

  1982cited by this paper
• Species variation in arterial-myocardial sensitivity to verapamil.

  1981cited by this paper
• Effects of niludipine (Bay-a-7168) on transmembrane action potentials of rabbit sinus node cells and atrial muscle fibers.

  1980cited by this paper
• Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.

  1980cited by this paper
• Tissue specificity of calcium-antagonistic properties of lidoflazine.

  1979cited by this paper
• Cerebral arterial spasm: part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries.

  1979cited by this paper
• Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema.

  1979cited by this paper
• Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.

  1978cited by this paper
• Comparative physiology of the cardiac pacemaker mechanism.

  1978cited by this paper
• The voltage- and time-dependent effects of (-)-verapamil on the slow inward current in isolated cat ventricular myocardium.

  1978cited by this paper
• Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium

  1977cited by this paper
• On the Mechanism Underlying the Action of D‐600 on Slow Inward Current and Tension in Mammalian Myocardium

  1977cited by this paper
• Differentiation of calcium activation mechanisms in vascular smooth muscle by selective suppression with verapamil and D 600-1.

  1975cited by this paper
• Effect of Verapamil on the Sinoatrial and Atrioventricular Nodes of the Rabbit and the Mechanism by Which it Arrests Reentrant Atrioventricular Nodal Tachycardia

  1974cited by this paper
• Excitation‐Contraction Coupling in Rabbit Aorta Studied by the Lanthanum Method for Measuring Cellular Calcium Influx

  1972cited by this paper
• Selective blockade of potassium-induced contractions of aortic strips by beta-diethylaminoethyl-diphenylpropylacetate (SKF 525A).

  1970cited by this paper
• Ultramicroelectrode recording from the cardiac pacemaker.

  1955cited by this paper

• Neuroprotective effect of the calcium channel blocker nilvadipine on retinal ganglion cell death in a mouse ocular hypertension model

  2023cites this paper
• (NH4)42[MoVI72MoV60O372(CH3COO)30(H2O)72] as a Heterogeneous Reusable Catalyst for Organic Reactions: Mini-Review

  2019cites this paper
• Extraordinary catalytic activity of a Keplerate-type giant nanoporous isopolyoxomolybdate in the synthesis of 1,8-dioxo-octahydroxanthenes and 1,8-dioxodecahydroacridines

  2015cites this paper
• 4-isoxazolyl-1,4-dihydropyridines: a tale of two scaffolds.

  2014cites this paper
• Performance Evaluation of Newly Prepared Alumina Supported Polyphosphoric Acid (PPA/Al2O3) as Efficient and Reusable Catalyst for the Synthesis of 1,8-Dioxodecahydroacridines

  2014cites this paper
• A Rapid and Green Method for Solvent-Free Synthesis of 1,8-Dioxodecahydroacridines Using Tetrabutylammonium Hexatungstate as a Reusable Heterogeneous Catalyst

  2012cites this paper
• Dihydropyridines: evaluation of their current and future pharmacological applications.

  2009cites this paper
• 1,4‐Dihydropyridines (DHPs) – a class of very potent drugs: syntheses of isotopically labeled DHP derivatives during the last four decades

  2007cites this paper
• Effect of the calcium antagonist nilvadipine on haemodynamics at rest and during cold stimulation in essential hypertension

  2004cites this paper
• Effects of a Ca2+ entry blocker (nilvadipine) on acute focal cerebral ischemia in rats

  2004cites this paper
• Stereocontrolled additions to dihydropyridines and tetrahydropyridines: Access to Nheterocyclic compounds related to natural products

  2001cites this paper
• Effects of nilvadipine on cytokine-levels and soluble factors in collagen disease complicated with essential hypertension.

  1999cites this paper
• Effects of novel pyridothiazepines and pyridothiazines on contractility of isolated guinea-pig heart muscle and vascular smooth muscle preparations.

  1999cites this paper
• Effects of two calcium channel blockers on messenger RNA expression of endothelin-1 and nitric oxide synthase in cardiovascular tissue of hypertensive rats.

  1999cites this paper
• Effect of Single Oral Administration of Nilvadipine on Cerebral Blood Flow in Chronic Cerebral Infarction

  1992cites this paper
• Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.

  1992cites this paper
• Effect of Nilvadipine on Balloon Catheterization-Induced Intimal Thickening of the Coronary Artery in Miniature Pigs

  1992cites this paper
• Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats.

  1991cites this paper
• Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.

  1991cites this paper
• Antiatherogenic Properties of Calcium Antagonists

  1991cites this paper
• 1,4‐Dihydropyridine: Einfluß von Chiralität und Konformation auf die Calcium‐antagonistische und ‐agonistische Wirkung

  1991cites this paper
• Cardiovascular properties of LF 2.0254, a new potent vasoselective calcium channel blocker with a slow onset of action

  1990cites this paper
• Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker.

  1989cites this paper
• Early detection of myocardial ischemia by myocardial free fatty acid extraction in patients with exercise-induced angina pectoris.

  1989cites this paper
• New generation dihydropyridine calcium entry blockers: in search of greater selectivity for one tissue subtype.

  1989cites this paper
• Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition--a pathogenic factor in atherosclerosis.

  1988cites this paper
• Prolonged inhibitory effects of nilvadipine (FR34235) following washout in isolated rabbit aorta and mesenteric artery.

  1988cites this paper
• Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.

  1988cites this paper
• Effect of a new calcium antagonist, nilvadipine, on variant angina pectoris evaluated by 24-hour Holter electrocardiography.

  1988cites this paper
• Effects of nilvadipine on the cardiovascular system in experimental animals.

  1988cites this paper
• The mode of vasoinhibitory action of a pyridazione derivative (MCI-154), a new cardiotonic agent, on contractile responses induced by alpha-adrenoceptor agonists and 45Ca influx in isolated vascular smooth muscles.

  1988cites this paper
• Pharmacokinetics of nilvadipine after single oral doses in healthy volunteers.

  1988cites this paper
• 運動誘発狭心症に対するNilvadipine (FK235) の血行動態効果

  1987cites this paper
• Clinical Evaluation of Antianginal Effects of a Single Dose of Nilvadipine (FK235) with Serial Multistage Treadmill Exercise Testing

  1987cites this paper
• Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery.

  1987cites this paper
• Effects of a new second generation calcium channel blocker, nilvadipine (FR34235), on exercise-induced hemodynamic changes in stable angina pectoris.

  1987cites this paper
• Mode of vasorelaxing action of 5-[3-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-1-oxopropyl]-2,3,4,5- tetrahydro-1,5-benzothiazepine fumarate (KT-362), a new intracellular calcium antagonist.

  1987cites this paper
• カルシウム拮抗剤FR34235(Nilvadipine)の抗動脈硬化作用に関する研究

  1987cites this paper
• Role of receptor reserve in the inhibition of alpha-1 adrenoceptor-mediated pressor responses by calcium antagonists in the pithed rat.

  1986cites this paper
• Effects of calcium channel entry blockers, nifedipine and nilvadipine, on colonic motor activity.

  1986cites this paper
• The Antihypertensive Effect and Pharmacokinetics of Nilvadipine (FK 235) in Essential Hypertension

  1986cites this paper
• Effect of Ca2+ Channel Antagonists on the Acrosome Reaction of Guinea Pig and Golden Hamster Spermatozoa

  1986cites this paper
• New dihydropyridine drug, nilvadipine, blocks the calcium slow action potential in rat-cultured aortic smooth muscle cells.

  1986cites this paper
• Calcium antagonism and calcium entry blockade.

  1986cites this paper
• Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.

  1986cites this paper
• The mode of vasorelaxant action of 2‐ aminoisoquinoline, 1.3 (2H.4H)‐dione, a novel ‘intracellular calcium inhibitor’

  1986cites this paper
• Comparison of the Calcium Antagonistic Activity of Nifedipine and FR34235 in the Canine Saphenous Vein

  1985cites this paper
• Chapter 7. Antihypertensive Agents

  1984cites this paper
• Advances in Cardiovascular Pharmacology

  1984cites this paper
• The inhibitory action of FR 34235 (a new Ca2+ entry blocker) as compared to nimodipine and nifedipine on the contractile response to norepinephrine, potassium and 5-hydroxytryptamine in rabbit basilar artery.

  1983cites this paper